ImmunityBio, Inc. (IBRX) Stock Overview
Explore ImmunityBio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
ImmunityBio, Inc. (IBRX)
Key Financials
Key Financials
Market Cap
7.6B
P/E Ratio
-8.50
EPS (TTM)
$-0.85
ROE
1.39%
IBRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ImmunityBio, Inc. (IBRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.41, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.76.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.50 and a market capitalization of 7.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.